This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Related letter  • Similar articles in this journal  Topic Collections  • Corneal Disorders  • Ophthalmological Disorders, Other  • Drug Therapy  • Drug Therapy, Other  • Humanities  • Medicine and the Media  • Alert me on articles by topic  Social Bookmarking   What's this?

Hugh R. Taylor, AC, MD, FRANZCO

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

As much as I respect the opinion of my erudite colleague, Dr Sommer, I believe he may have misread the study by Solomon and colleagues¹ in his recent editorial.²

Sommer reports that the study of Solomon "found that a single dose (of azithromycin) virtually eliminated infection for 2 years." While it is true that a single dose of azithromycin was given and the title of the article reemphasizes this misconception, the authors do state that "for ethical reasons at 6, 12 and 18 months, we gave 2 tubes of tetracycline to subjects with active disease."¹

This article, with its misleading title, has been frequently misquoted as reflecting the effect of a single dose of azithromycin where, in fact, it truly represents a hybrid treatment model with initial azithromycin and 6 monthly retreatments with tetracycline ointment. A now somewhat outdated Cochrane review considered topical tetracycline . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Frequency of Antibiotic Coverage and Elimination of Blinding Trachoma
Alfred Sommer
Arch Ophthalmol. 2008;126(7):1000-1001.
EXTRACT | FULL TEXT  

RELATED LETTER

Misleading Titles Cause Confusion—Reply
Alfred Sommer
Arch Ophthalmol. 2009;127(2):225.
EXTRACT | FULL TEXT